Suppliers in Columbus, NE
12 Medicare Suppliers found. Showing 1 - 12
 Tooley Drug And Homecare Long Term Care Pharmacy Location: 2615 13th St, Columbus, Nebraska 68601 Phone: (402) 564-7397 |
Cvs Pharmacy #10041 Durable Medical Equipment & Medical Supplies Location: 2307 23rd St, Columbus, Nebraska 68601 Phone: (402) 564-5105 |
Walmart Pharmacy 10-0774 Durable Medical Equipment & Medical Supplies Location: 818 E 23rd St, Columbus, Nebraska 68601 Phone: (402) 563-4571 |
Walgreens #12115 Durable Medical Equipment & Medical Supplies Location: 2320 23rd St, Columbus, Nebraska 68601 Phone: (402) 563-3588 |
B&r Stores, Inc Community/Retail Pharmacy Location: 3318 23rd St, Columbus, Nebraska 68601 Phone: (402) 563-3349 |
Hy Vee Pharmacy (1078) Durable Medical Equipment & Medical Supplies Location: 3010 23rd Street, Columbus, Nebraska 68601 Phone: (402) 562-7668 |
Bobs U Save Pharmacy Medicare Supplier Location: 2759 33rd Ave, Columbus, Nebraska 68601 Phone: (402) 564-2883 |
Promedcare DME Supplier - Oxygen Equipment & Supplies Location: 3100e 23rd St 4, Columbus, Nebraska 68601 Phone: (402) 564-7900 |
See The Trainer-columbus Medicare Supplier Location: 4508 38th Street, Columbus, Nebraska 68601 Phone: (402) 606-4204 |
Eye Physicians Columbus Pc Medicare Supplier Location: 3772 43rd Ave, Columbus, Nebraska 68601 Phone: (402) 563-3686 |
Optometric Center Of Columbus Pc Medicare Supplier Location: 3702 23rd St, Columbus, Nebraska 68601 Phone: (402) 564-2020 |
Eyecare Associates Of Columbus Pc Medicare Supplier Location: 605 23rd St, Columbus, Nebraska 68601 Phone: (402) 564-0545 |
News Archive
Social Security Administration adds early-onset Alzheimer's disease to Compassionate Allowances list: AFA lauds
The Alzheimer's Foundation of America (AFA) today applauded the Social Security Administration for including early-onset Alzheimer's disease among the medical conditions that will be given automatic approval for disability benefits, rather than have individuals go through what could be a lengthy qualification process.
FDA places Geron Corporation's IND for spinal cord injury on clinical hold
Geron Corporation (Nasdaq:GERN) today announced that its IND (Investigational New Drug application) for GRNOPC1, a cell therapy for neurologically complete, subacute spinal cord injury, has been placed on clinical hold by the FDA pending the agency's review of new nonclinical animal study data submitted by the company. A clinical hold is an order that the FDA issues to a sponsor to delay a proposed trial or to suspend an ongoing trial.
UC3M researchers introduce Laboratory of Discrimination and Inequality
Researchers from the Universidad Carlos III de Madrid (UC3M) have introduced the Laboratory of Discrimination and Inequality (D-Lab), which aims to advance the scientific study of discrimination and social inequality by promoting research and methodological innovation.
New technique offers hope for stroke sufferers
If a stroke patient doesn't get treatment within approximately the first three hours of symptoms, there's not much doctors can do to limit damage to the brain.
Further evidence that angiogenesis drugs can be much more effective when combined with chemotherapy
Scientists have thought that one way to foil a tumor from generating blood vessels to feed its growth - a process called angiogenesis - was by creating drugs aimed at stopping a key vessel growth-promoting protein.
› Verified 2 days ago